Chlamydiae

Laboratory Diagnosis of Bacterial Infections

Volumn , Issue , 2001, Pages 795-822

  Campbell, Lee Ann ^a   Marrazzo, Jeanne M ^b   Stamm, Walter E ^b   Kuo, Cho Chou ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 8544279829     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (183)

1. Kuo C-C, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 1995;8:451-461.
2. Saikku P, Wang S-P, Kleemola M, Brander E, Rusanen E, Grayston JT. An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci. J Infect Dis 1985; 151:832-839.
3. Grayston JT, Kuo C-C, Wang S-P, Altman J. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med 1986; 315:161-168.
4. Grayston JT, Kuo C-C, Campbell LA, Wang S-P. Chlamydia pneumoniae sp. nov. for Chlamydia strain TWAR. lnt J Syst Bacteriol 1988; 39:88-90.
5. Meyer KF. Ornithosis and psittacosis. In: Biester HE, Schwarte LH. eds. Diseases of Poultry. Ames, Iowa: Iowa State College Press, 1952:569-618.
6. Stamm WE, Holmes KK. Chlamydia trachomatis infections of the adult. In: Holmes KK, Mardh P-A, Sparling PF, eds. Sexually Transmitted Diseases. New York: McGraw-Hill, 1999:407-422.
7. Beatty WL, Momson RP, Byrne GI. Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev 1994; 58:686-699.
8. Stamm WE, Wagner KF, Amsel R, Alexander ER, Turck M, Counts GW, Holmes KK. Causes of the acute urethral syndrome in women. N Engl J Med 1980; 303:409-415.
9. Paavonen J, Kiviat N, Brunham RC, Stevens CE, Kuo CC, Stamm WE, Miettinen A, Soules M, Eschenbach DA, Holmes KK. Prevalence and manifestations of endometritis among women with cervicitis. Am J Obstet Gynecol 1985; 152:280-286.
10. Stamm WE, Guinan ME, Johnson C, Starcher T, Holmes KK, McCormack WM. Effect of treatment regimens for N. gonorrlioeae on simultaneous infection with C. trachomatis. N Engl J Med 1984; 310:545-549.
11. Schachter J, Grossman M, Sweet RL, Holt J, Jordan C, Bishop E. Prospective study of perinatal transmission of Chlamydia trachomatis. JAMA 1986; 255:3374-3377.
12. Weiss SG, Newcomb RW, Beem MO. Pulmonary assessment of children after chlamydial pneumonia of infancy. J Pediatr 1986; 108:659-664.
13. Cates W, Joesoef MR, Goldman MB. Atypical pelvic inflammatory disease: can we identify the clinical predictors? Am J Obstet Gynecol 1993; 169:341-346.
14. Cates W, Rolfs RT, Aral SO. Sexually transmitted diseases, pelvic inflammatory disease, and infertility: an epidemiologic update. Epidemiol Rev 1990; 12:199-220.
15. Cates W, Wasserheit JN. Genital chlamydial infections: epidemiology and reproductive sequelae. Am J Obstet Gynecol 1991; 164:1771-1781.
16. Cumining DC, Honore LH, Scott JZ, Williams KE. Microscopic evidence of silent inflammation in grossly normal fallopian tubes with ectopic pregnancy. Int J Fertil 1988; 33:324-328.
17. Chow JM, Yonekura ML, Richwald GA, Greenland S, Sweet RL, Schachter J. The association between Chlamydia trachomatis and ectopic pregnancy. JAMA 1990; 263:3164-167.
18. Marana R, Sanna A, Lucisano A, Dell'Acqua S, Leone F, Mancuso S. High prevalence of silent chlamydia colonization of the tubal mucosa in infertile women. Fertil Steril 1990; 53:354-356.
19. Patton DL, Kuo C-C, Wang S-P, Halbert SA. Distal tubal obstruction induced by repeated Chlamydia trachomatis salpingeal infections in pig-tailed macaques. J Infect Dis 1987; 155:1292-1299.
20. Brunham RC, Binns B, McDowell J, Paraskevas M. Chlamydia trachomatis infection in women with ectopic pregnancy. Obstet Gynecol 1986; 67:722-726.
21. Hillis SD, Owens LM, Marchbanks PA, Amsterdam LE, MacKenzie WR. Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease. Am J Obstet Gynecol 1997; 176:103-107.
22. Van der Laar MJ, van Duynhoven YT, Fennema JS, Ossewaarde JM, van den Brule AJ, van Doomum GJ, Coutinho RA, van den Hoek JA. Differences in clinical manifestations of genital chlamydial infections related to serovars. Genitourin Med 1996; 72:261-265.
23. Dean D, Schachter J, Dawson CR, Stephens RS. Comparison of the major outer membrane protein variant sequence regions of B/Ba isolates: a molecular epidemiologic approach to Chlamydia trachomatis infections. J Infect Dis 1992; 166:383-392.
24. Stamm WE, Hicks CB, Martin DH, Leone P, Hook EW, Cooper RH, Cohen RH, Batteiger BE, Workowski K, McCormack WM. Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study. JAMA 1995; 274:577-579.
25. Cohen DA, Nsuami M, Etamc RB, Tropez-Sims S, Abdalian S, Farley TA, Martin DH. A school-based Chlamydia control program using DNA amplification technology. Pediatrics 1998; 101:E1.
26. Marrazzo JM, White CL, Lafferty WE, Krekeler B, Celum CL, Stamm WE, Handsfield HH. Community- based urine screening for Chlamydia trachomatis infection by ligase chain reaction. Ann Intern Med 1997; 127:796-803.
27. Beutler AM, Whittum-Hudson JA, Nanagara R, Schumacher HR, Hudson AP. Intracellular location of inap- parently infecting Chlamydia in synovial tissue from patient with Reiter’s syndrome. Immunol Res 1994; 13:163-171.
28. Sieper J, Kingsley G, Palacios-Boix A, Pitzalis C, Trehame J, Hughes R, Keat A, Panayi GS. Synovial T lymphocyte-specific immune response to Chlamydia trachomatis in Reiter’s disease. Arthritis Rheum 1991; 34:588-598.
29. Amor B. Reiter's syndrome. Diagnosis and clinical features. Rheum Dis Clin North Am 1998; 24:677-695.
30. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. MMWR 1998; 47:RR-1.
31. Martin DH, Mroczkowski TF, Dalu ZA, McCarty J, Jones RB, Hopkins SJ, Johnson RB. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. N Engl J Med 1992; 327:921-925.
32. Brunham RC, Peeling RW. Chlamydia trachomatis antigens: role in immunity and pathogenesis. Infect Agents Dis 1994;3:218-233.
33. Jackson LA, Campbell LA, Schmidt RA, Kuo C-C, Cappuccio AL, Lee MJ, Grayston JT. Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma. Evaluation of the innocent bystander hypothesis. Am J Pathol 1997; 150:1785-1790.
34. Boman J, Soderberg S, Forsberg J, Birgander LS, Allard A, Persson K, Jidell E, Kumlin U, Juto P, Waldenstrom A, Wadell G. High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. J Infect Dis 1998; 178:274-277.
35. Moazed TC, Kuo C-C, Grayston JT, Campbell LA. Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infect Disl998; 177:1322-1325.
36. Kuo C-C, Campbell LA. Detection of Chlamydia pneumoniae in arterial tissues. J Infect Dis 2000; Suppl. (In press)
37. Moazed TC, Kuo C-C, Grayston JT, Campbell LA. Murine models of Chlamydia pneumoniae infection and atherosclerosis. J Infect Dis 1997; 175:883-890.
38. Grayston JT. Infections caused by Chlamydia pneumoniae strain TWAR. Clin Infect Dis 1992; 15:757-763.
39. Thom DH, Grayston JT, Wang S-P, Kuo C-C, Altman J. Chlamydia pneumoniae strain TWAR, Mycoplasma pneumoniae and viral infections in acute respiratory disease in a university student health clinic population. Am J Epidemiol 1990; 132:248-256.
40. Kauppinen M, Saikku P, Kujala P, Herva E, Syrjala H. Clinical picture of community-acquired pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia. Thorax 1996; 51:185-189.
41. Augenbraun MH, Roblin PM, Chirgwin K, Landman D, Hammerschlag MR. Isolation of Chlamydia pneumoniae from the lungs of patients injected with the human immunodeficiency virus. J Clin Microbiol 1991; 29:401-402.
42. Gaydos CA, Fowler CL, Gill VJ, Eiden JJ, Quinn TC. Detection of Chlamydia pneumoniae by polymerase chain reaction-enzyme immunoassay in an immunocompromised population. Clin Infect Dis 1993; 17:718-723.
43. Cosentini R, Esposito S, Blasi F, Clerici Schoeller M, Pinzani R, Tarsis P, Fagetti L, Arosio C, Principi N, Allegra L. Incidence of Chlamydia pneumoniae infection in vertically HIV-1 infected children. Eur J Clin Microbiol Infect Dis 1998; 17:720-723.
44. Comandini UV, Maggi P Santopadre P, Monno R, Angarano G, Vullo V. Chlamydia pneumoniae respiratory infections among patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis 1997; 16:720-726.
45. Hashiguchi K, Ogawa H, Suzuki T, Kazuyama Y. Isolation of Chlamydia pneumoniae from the maxillary sinus of a patient with purulent sinusitis. Clin Infect Dis 1992; 15:570-571.
46. Ogawa H, Hashiguchi K, Kazuyama Y. Recovery of a Chlamydia pneumoniae in six patients with otitis media and effusion. J Laryngol Otol 1992; 106:490-492.
47. Mame TH, Marczy M, Mann OE, Landymore RW, Raza A, Wang S-P, Grayston JT. Culture-negative endocarditis probably due to Chlamydia pneumoniae. J Infect Dis 1990; 161:127-129.
48. Michel D, Antoine JC, Pozetto B, Gaudin G, Lucht F. Lumbosacral mengoradiculitis associated with Chlamydia pneumoniae infection. J Neurol Neurosurg Psychiatr 1992; 55:511.
49. Hahn DL, Dodge RW, Golubjatnikow R. Association of C. pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA 1991; 266:225-230.
50. Beaty CD, Grayston JT, Wang S-P, Kuo C-C, Reto RS, Martin TR. Chlamydia pneumoniae, strain TWAR, infection in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1991; 144:1408-1410.
51. Sundolof B, Gnarpe H, Gnarpe J. An unusual manifestation of Chlamydia pneumoniae infection: meningitis, hepatitis, iritis, and atypical erythema nodosum. Scand J Infect Dis 1993; 25:259-261.
52. Emtell M, Ljunggren K, Gadd T, Persson K. Erythema nodosum - a manifestation of Chlamydia pneumoniae (strain TWAR) infection. Scand J Infect Dis 1989; 21:693-696.
53. Haidl S, Ivarsson S, Bjerre I, Persson K. Guillain-BarTe syndrome after Chlamydia pneumoniae infection. N Engl J Med 1992; 326:576-577.
54. Braun J, Laitko S, Trehame J, Eggens U, Wu P, Distler A, Sieper J. Chlamydia pneumoniae - a new causative agent of reactive arthritis and undifferentiated oligoarthritis. Ann Rheum Dis 1994; 53:100-105.
55. Balin BJ, G'erard HC, Arking EJ, Appelt DM, Branigan PJ, Abrams JT, Whittum-Hudson JA, Hudson AP. Identification of localization of Chlamydia pneumoniae in the Alzheimer’s brain. Med Microbiol Immunol Berl 1998; 187:23-42.
56. Sriram S, Stratton CW, Yao SY, Tharp A, Ding L, Bannan JD, Mitchell WM. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann Neurol 1999; 46:6-14.
57. Grayston JT, Kuo C-C, Campbell LA, Wang S-P, Jackson LA. Chlamydia pneumoniae and cardiovascular disease. Cardiologia 1997; 42:1145-1151.
58. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: Is there a link? Lancet 1997; 350:430-436.
59. Campbell LA, Kuo C-C, Grayston JT. Chlamydia pneumoniae and cardiovascular disease. Emerg Infect Dis 1998;4:571-579.
60. Campbell LA, Moazed TC, Kuo C-C, Grayston JT. Preclinical models for Chlamydia pneumoniae and cardiovascular disease: hypercholestemic mice. Clin Microbiol Infect 1998; 4.S23-S32.
61. Kuo C-C, Grayston JT. In vitro drug susceptibility of Chlamydia sp. strain TWAR. Antimicrob Agents Chemother 1988; 32:257-258.
62. Hammerschlag MR, Chirgwin K, Roblin PM, Gelling M, Dumomay W, Mandel L, Smith P, Schachter J. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis 1992- 14: 178-182.
63. Welsh LE, Gaydos CA, Quinn TC. In vitro evaluation of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis, and Chlamydia pneumoniae. Antimicrob Agents Chemother 1992; 36:252-253.
64. Hammerschlag MR, Qumei KK, Roblin PM. In vitro activities of azithromycin, l-ofloxacin, and other antibiotics against Chlamydia pneumoniae. Antimicrob Agents Chemother 1992; 36:1573-154.
65. Jackson LA, Grayston JT. Chlamydia pneumoniae. In: Yu VL, Merigan TC Jr, Barriere SL, eds. Antimicrobial Therapy and Vaccines. Baltimore:Williams & Wilkins, 1999:583-586.
66. Levison DA, Guthrie W, Ward C, Green DM, Roberson PGC. Infective endocarditis as part of psittacosis. Lancet 1971;2:844-847.
67. Jones RB, Priest JB, Kuo C-C. Subacute chlamydial endocarditis. JAMA 1982; 247:655-658.
68. Lamaury I, Sotto A, Le Quellec A, Perez C, Boussagol B, Ciurana AJ. Chlamydia psittaci as a cause of lethal bacterial endocarditis. Clin Infect Dis 1993; 17:821-822.
69. Jannach JR. Myocarditis in infancy with inclusion characteristic of psittacosis. Am J Dis Child 1958; 96:734-740.
70. Meyer KF. The present status of psittacosis - ornithosis. Arch Environ Health 1969; 19:461-466
71. Meyer KF. The host spectrum of psittacosis — lymphogranuloma venereum agents. Am J Ophthalmol 1967; 63:1225-1246.
72. Baker JA. A virus obtained from a pneumonia of cats and its possible relation to the cause of atypical pneumonia in man. Science 1942; 96:475-476.
73. Barwell CF. Laboratory infection of man with virus of enzootic abortion of ewes. Lancet 1955; 2:1369-1371.
74. Barnes MG, Brainered H. Pneumonitis with alveolar capillary block in a cattle rancher exposed to epizootic bovine abortion. N Engl J Med 1964; 271:981-985.
75. Schachter J, Ostler HB, Meyer KF. Human infection with the agent of feline pneumonitis. Lancet 1969; 1:1063-1065.
76. Beer RJ. Bradford WP, Hart RJC. Pregnancy complicated by psittacosis acquired from sheep. BMJ 1982; 284:1156-1157.
77. Kaiser Family Foundation. Sexually transmitted diseases in America: how many and at what cost? Report of the Kaiser Family Foundation, December, 1998.
78. Centers for Disease Control. Chlamydia trachomatis genital infections—United States, 1995. MMWR 1997; 46:193-198.
79. Centers for Disease Control. Ten leading nationally notifiable infectious diseases—United States, 1995. MMWR 1996; 45:883-884.
80. Suchland KL, Counts JM, Stamm WE. Laboratory methods for detection of Chlamydia trachomatis: survey of laboratories in Washington State. J Clin Microbiol 1997; 35:3210-3214.
81. Wills JM, Watson G, Lusher M, Mair TS, Wood D, Richmond SJ. Characterization of Chlamydia psittaci isolated fromahorse. Vet Microbiol 1990; 24:11-19.
82. Giijes AA, Hugall A, Graham DM, McCaul TF, Lavin MF. Comparison of type I and type II Chlamydia psittaci strains infecting koalas (Phascolarctos cinereus). Vet Microbiol 1993; 37:65-83
83. Thenussen HJH, Lemmens-den Toom NA, Burggraaf A, Stolz E, Michel MF. Influence of temperature and relative humidity on the survival of Chlamydia pneumoniae in aerosols. Appl Environ Microbiol 1993; 59:2589-2593.
84. Falsey AR, Walsh EE. Transmission of Chlamydia pneumoniae. J Infect Dis 1993; 168:453-6.
85. Schachter J. Biology of Chlamydia trachomatis. In: Holmes KK, Mardh P-A, Sparling PF, eds. Sexually Transmitted Diseases. New York:McGraw-Hill, 1999:391-406.
86. Hatch TP, Miceli M, Sublett JE. Synthesis of disulfide-bonded membrane proteins during the developmental cycle of Chlamydia psittaci and Chlamydia trachomatis. J Bacteriol 1986; 165:379-385.
87. Schachter J, Stamm WE. Chlamydia. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Tolken RH - eds. Manual of Clinical Microbiology. Washington, D.C.:American Society for Microbiology, 1999:795-806.
88. Stamm WE, Tamm MR, Koester M, Cles LD. Detection of Chlamydia trachomatis inclusions in McCoy cell cultures with fluorescein-conjugated monoclonal antibodies. J Clin Microbiol 1983; 17:666-668.
89. Wang S-P, Grayston JT. Chlamydia pneumoniae elementary body antigenic reactivity with fluorescent antibody is destroyed by methanol. J Clin Microbiol 1991; 29:1539-1541.
90. Chi EY, Kuo C-C, Grayston JT. Unique ultrastructure in the elementary body of Chlamydia sp. TWAR. J Bacteriol 1987; 169:3757-3763.
91. Kanamoto Y, Iikima Y, Miyashita N, Matsumoto A, Sakano T. Antigenic characterization of Chlamydia pneumoniae isolated in Hiroshima, Japan. Microbiol Immunol 1993; 37:495-498.
92. Perez Melgosa M, Kuo C-C, Campbell LA. Outer membrane complex proteins of Chlamydia pneumoniae. FEMS Microbiol Lett 1993; 112:199-204.
93. Shor A, Kuo C-C, Patton DL. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J 1992; 82:158-161.
94. Grayston JT, Wang S-P, Yeh LJ, Kuo C-C. Importance of reinfection in the pathogenesis of trachoma. Rev Infect Dis 1985;7:717-725.
95. Brunham RC, MacLean IW, Binns B, Peeling RW. Chlamydia trachomatis: its role in tubal infertility. J Infect Dis 1985; 152:1275-1282.
96. Brunham RC, Peeling R, MacLean I, Kosseim ML, Paraskevas M. Chlamydia trachomatis-associated ectopic pregnancy: serologic and histologic correlation. J Infect Dis 1992; 165:1076-1081.
97. Hahn DL. Chlamydia pneumoniae, asthma, and COPD: what is the evidence? Ann Allergy Asthma Immunol 1999; 83:271-288.
98. Kuo C-C. Pathologic manifestation of chlamydial infection. Am Heart J 1999; 138:S496-S499.
99. Kuo C-C, Campbell LA. Is infection with Chlamydia pneumoniae a causative agent in atherosclerosis? Mol Med Today 1998; 4:426-430.
100. Lampe MF, Wong KG, Kuehl LM, Stamm WE. Chlamydia trachomatis major outer membrane protein variants escape neutralization by both monoclonal antibodies and human immune sera. Infect Immun 1997; 65:317-319.
101. Witkin SS, Jeremias J, Toth M, Ledger WJ. Cell-mediated immune response to the recombinant 57 kDa heat- shock protein of Chlamydia trachomatis in women with salpingitis. J Infect Dis 1993; 167:1379-1383.
102. Morrison RP, Belland RJ, Lyng K, Caldwell HD. Chlamydial disease pathogenesis. The 57 kD chlamydial hypersensitivity antigen is a stress response protein. J Exp Med 1989; 170: 1271.
103. Peeling RW, Brunham RC. Chlamydiae as pathogens: new species and new issues. Emerg Infect Dis 1996; 2:307-319.
104. Persson K, Osser S, Birkelund S, Christiansen G, Brade H. Antibodies to Chlamydia trachomatis heat shock proteins in women with tubal factor infertility are associated with prior infection by C. trachomatis but not by C. pneumoniae. HumReprod 1999; 14:1969-1973.
105. Chemesky M. Can serology diagnose upper genital tract Chlamydia trachomatis infections? Studies on women with pelvic pain, with or without chlamydial plasmid DNA in endometrial biopsy tissue. Sex Transm Dis 1998;25:14-19.
106. Van Voorhis WC, Barrett LK, Sweeney YT, Kuo C-C, Patton DL. Analysis of lymphocyte phenotype and cytokine activity in the inflammatory infiltrates of the upper genital tract of female macaques infected with Chlamydia trachomatis. J Infect Dis 1996; 174:647-650.
107. Levitt D, Berol J. The immunobiology of Chlamydia. Immunol Today 1987; 8:246-251.
108. Puolakkainen M, Parker J, Kuo C-C, Grayston JT, Campbell LA. Further characterization of Chlamydia pneumoniae specific monoclonal antibodies. Microbiol Immunol 1995; 39:551-554.
109. Campbell LA, Kuo C-C, Wang S-P, Grayston JT. Serological response to Chlamydia pneumoniae infection. J Clin Microbiol 1990; 28:1261-1264.
110. Carter MW, al-Mahdawi S, Giles IG, Trehame JD, Ward ME, Clarke IN. Nucleotidc sequence and taxonomic value of the major outer membrane protein gene of Chlamydia pneumoniae IOL-207. J Gen Microbiol 1991; 137:465-475.
111. Kaltenboeck B, Kousoulas KG, Storz J. Structure of and allelic diversity and relationship among the major outer membrane protein (ompA) genes of the four chlamydial species. J Bacteriol 1993; 175:487-502.
112. Jantos CA, Heck S, Roggendorf R, Sen-Gupta M, Hegemann JH. Antigenic and molecular analyses of different Chlamydia pneumoniae strains. J Clin Microbiol 1997; 35:620-623.
113. Gaydos CA, Quinn TC, Bobo D, Eiden JJ. Similarity of Chlamydia pneumoniae strains in the variable domain IV region of the major outer membrane protein gene. Infect Immun 1992; 60:5319-5323.
114. Freidank HM, Herr AS, Jacobs E. Identification of Chlamydia pneumoniae-specific protein antigens in im- munoblots. Eur J Clin Microbiol Infect Dis 1993; 12:947-951.
115. Lijma Y, Miyashita N, Kishimoto T, Kanamoti Y, Soejima R, Matsumoto A. Characterization of Chlamydia pneumoniae species-specific proteins immunodominant in humans. J Clin Microbiol 1994; 32:583-588.
116. Kol A, Sukhova GK, Lichtman AH, Libby P. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation 1998; 98:300-307.
117. Surcel HM, Syrjala H, Leinonen M, Saikku P, Herva E. Cell-mediated immunity to Clilamvdia pneumoniae measured as lymphocyte blast transformation in vitro. Infect Immun 1993; 61:2196-2199.
118. Brunham RC, Kuo C-C, Cles L, Holmes KK. Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix. Infect Immun 1983; 39:1491-1494.
119. Heinemann M, Susa M, Simnacher U, Marre R, Essig A. Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line. Infect Immun 1996; 64:4872-4887.
120. Molestina RE, Dean D, Ramirez JA, Summersgill JT. Characterization of a strain Chlamydia pneumoniae isolated from a coronary atheroma by analysis of the ompl gene and biological activity in human endothelial cells. Infect Immun 1998;66:1360-1376.
121. Black CM, Bullard JC, Staton GW, Jr, Hutwagner LC, Perez RL. Seroprevalence of Chlamydia pneumoniae antibodies in patients with pulmonary sarcoidosis in North Central Georgia. In: Mardh P-A, La Placa M, Ward ME, eds. Proceedings of the European Society for Chlamydial Research. Stockholm:Almquist & Wicksell International, 1992:175.
122. Gronhagen-Riska C, Saikku P, Riska H, Froseth B, Grayston JT. Antibodies to TWAR-a novel type of Chlamydia - in sarcoidosis. In: Grassi C, Rizzato G, Pozzi E, eds. Sarcoidosis and Other Granulomatous Disorders. Amsterdam:Excerpta Medica, 1988:297-391.
123. Moncada J, Schachter J, Shipp M, Bolan G, Wilber J. Cytobrush in collection of cervical specimens for detection of Chlamydia trachomatis. J Clin Microbiol 1989; 27:1863-1866.
124. Stamm WE, Tamm MR, Koester M, Cles LD. Detection of Chlamydia trachomatis inclusions in McCoy cell cultures with fluorescein-conjugated monoclonal antibodies. J Clin Micro 1983; 17:666-668.
125. Black CM. Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev 1997; 10:160-184.
126. Marrazzo JM, Celum CL, Whittington WL, Krekeler B, Clark A, Cles L, Handsfield HH, Stamm, WE. Optimizing the use of urine ligase chain reaction assay for diagnosing Chlamydia trachomatis urethral infection in male STD clinic clients. 9th International Symposium on Human Chlamydial Infection. Napa, CA, June 21-26. 1998:591-594.
127. Stamm WE, Harrison HR, Alexander ER, Cles LD, Spence MR, Quinn TC. Diagnosis of Chlamydia trachomatis infection by direct immunofluorescence staining of genital secretions—a multicenter trial. Ann Intern Med 1984; 101:683-641.
128. Pasternack R, Vuorinen P, Kuukankorpi A, Pitkajarvi T, Miettinen A. Detection of CT infections in women by Amplicor PCR: comparison of diagnostic performance with urine and cervical specimens. J Clin Microbiol 1996; 34:995-998.
129. Schwebke JR, Clark AM, Pettinger MB, Nsubga P, Stamm WE. Use of a urine enzyme immunoassay as a diagnostic tool for Chlamydia trachomatis urethritis in men. J Clin Microbiol 1991; 29:2446-2449.
130. Pasternack R. Comparison of a transcription-mediated amplification assay and polymerase chain reaction for detection of Chlamydia trachomatis in first-void urine. Eur J Clin Microbiol Infect Dis 1999; 18:142-144.
131. Stary A. Performance of transcription-mediated amplification and ligase chain reaction assays for detection of chlamydial infection in urogenital samples obtained by invasive and nonmvasive methods. J Clin Microbiol 1998; 36:2666-2670.
132. Girdner JL, Cullen AP, Salama TG, He L, Lorincz A, Quinn TC. Evaluation of the digene hybrid capture II CT-ID test for detection of Chlamydia trachomatis in endocervical specimens. J Clin Microbiol 1999; 37:1579-1581.
133. Stary A, Tomazic-Allen S, Choueiri B, Burczak J, Steyrer K, Lee H. Comparison of DNA amplification methods for the detection of Chlamydia trachomatis in first-void urine from asymptomatic military recruits. Sex Transm Dis 1996; 23:97-102.
134. Chemesky MA, Jang D, Lee H, Hu H, Sellors J, Tomazic-Allen SJ, Mahony JB. Diagnosis of Chlamydia trachomatis infections in men and women by testing first-void urine by ligase chain reaction. J Clin Microbiol 1994;32:2682-2685.
135. Ridgway GL, Mumtaz G, Robinson AJ, Franchini M, Carder C, Burczak J, Lee H. Comparison of the ligase chain reaction with cell culture for the diagnosis of Chlamydia trachomatis infection in women. J Clin Pathol 1996;49:116-119.
136. Schachter J, Moncada J, Whidden R, Shaw H, Bolan G, Burczak JD, Lee HH. Noninvasive tests for diagnosis of Chlamydia trachomatis infection: application of ligase chain reaction to first-catch urine specimens of women. J Infect Dis 1995; 172:1411-1414.
137. Lee H H, Chemesky MA, Schachter J, Burczak JD, Andrews WW, Muldoon S, Leckie G, Stamm WE. Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine. Lancet 1995;345:213-216.
138. Rumpianesi F, Donati M, Negosanti M, D’Antuono A, LaPlaca M, Cevenini R. Detection of Chlamydia trachomatis by a ligase chain reaction amplification method. Sex Transm Dis 1996; 23:177-180.
139. Schachter J, Stamm WE, Quinn TC, Andrews WW, Burczak JD, Lee H. Ligase chain reaction to detect Chlamydia trachomatis infection of the cervix. J Clin Microbiol 1994; 32:2540-2543.
140. Domeika M, Bassiri M, Butrimiene I, Venalis A, Ranceva J, Vasjanova V. Evaluation of vaginal introital sampling as an alternative approach for the detection of genital Chlamydia trachomatis infection in women. Acta Obstet Gynecol Scand 1999; 78:131-136.
141. Polaneczky M. Use of self-collected vaginal specimens for detection of Chlamydia trachomatis infection. Obstet Gynecol 1998; 91:375-378.
142. Mahony JB, Luinstra KE, Sellors JW, Jang D, Chemesky MA. Confirmatory polymerase chain reaction testing for Chlamydia trachomatis in first-void urine from asymptomatic and symptomatic men. J Clin Microbiol 1992;30:2241-2245.
143. Bauwens JE, Clark AM, Loeffelholz MJ, Herman SA, Stamm WE. Diagnosis of Chlamydia trachomatis urethritis in men by polymerase chain reaction assay of first-catch urine. J Clin Microbiol 1993; 31:3013-3016.
144. Quinn TC, Welsh L, Lentz A, Crotchfelt K, Zenilman J, Newhall J, Gaydos C. Diagnosis by AMPL1COR PCR of Chlamydia trachomatis in urine samples from women and men attending sexually transmitted disease clinics. J Clin Microbiol 1996; 4:1401-1406.
145. Toye B, Peeling RW, Jessamine P, Claman P, Gemmill 1. Diagnosis of Chlamydia trachomatis infections in asymptomatic men and women by PCR assay. J Clin Microbiol 1996; 34:1396-400.
146. Bianchi A, Scieux C, Brunat N, Vexiau D, Kermanach M, Pezin P, Janier M, Morel P, Lagrange PH. An evaluation of the polymerase chain reaction amplicor Chlamydia trachomatis in male urine and female urogenital specimens. Sex Transm Dis 1994; 21:196-200.
147. Bauwens JE, Clark AM, Stamm WE. Diagnosis of Chlamydia trachomatis endocervical infections by a commercial polymerase chain reaction assay. J Clin Microbiol 1993; 31:3023-3029.
148. Mahony J, Chong S, Jang D, Luinstra K, Faught M, Dalby D, Sellors J, Chemesky M. Urine specimens from pregnant and nonpregnant women inhibitory to amplification of Chlamydia trachomatis nucleic acid by PCR, ligase chain reaction, and transcription-mediated amplification: identification of urinary substances associated with inhibition and removal of inhibitory activity. J Clin Microbiol 1998; 36:3122-3126.
149. Homer PJ, Crowley T, Leece J Hughes A, Smith GD, Caul EO. Chlamydia trachomatis detection and the menstrual cycle. Lancet 1998; 351:341-342.
150. Jensen IP, Thorsen P, Moller BR. Sensitivity of ligase chain reaction assay of urine from pregnant women for Chlamydia trachomatis. Lancet 1997; 349:329-330.
151. Kluytmans JAJW, Goessens WHF, Mouton JW, van Rijsoort-Vos JH, Niesters HGM, Quint WGV, Habbema L, Stolz E, Wagenvoort JHT. Evaluation of Clearview and Magic Lite tests, polymerase chain reaction, and cell culture for detection of Chlamydia trachomatis in urogenital specimens. J Clin Microbiol 1994; 31:3204-3210.
152. Pate MS, Dixon PB, Hardy K, Crosby M, Hook EW 3rd. Evaluation of the Biostar Chlamydia OlA assay with specimens from women attending a sexually transmitted disease clinic. J Clin Microbiol 1998; 36:2183-2186.
153. Kacena KA, Quinn SB, Howell R, Madico GE, Quinn TC, Gaydos CA. Pooling urine samples for ligase chain reaction screening for genital Chlamydia trachomatis infection in asymptomatic women. J Clin Microbiol 1998; 36:481-485.
154. Peeling RW. Pooling of urine specimens for PCR testing: a cost saving strategy for Chlamydia trachomatis control programmes. Sex Transm Dis 1998; 74:66-70.
155. Clark AM, Marrazzo JM, Krekler B, Handsfield HH, Stamm WE. Use of pooled LCR specimens for chlamydia screening. Abstracts of the Thirteenth Meeting of the Inti Soc for STD Research, July 1999, Denver CO; p 33, #019.
156. Cles LD, Stamm WE. Use of HL cells for improved isolation and passage of Chlamydia pneumoniae. J Clin Microbiol 1990; 28:938-940.
157. Kuo C-C, Grayston JT. A sensitive cell line, HL cells, for isolation and propagation of Chlamydia pneumoniae strain TWAR. J Infect Dis 1990; 162:755-758.
158. Wong KH, Skelton SK, Chan YK. Efficient culture of Chlamydia pneumoniae with cell lines derived from the human respiratory tract. J Clin Microbiol 1992; 30:1625-1630.
159. Roblin PM, Dumomay W, Hammerschlag MR. Use of Hep-2 cells for improved isolation and passage of Chlamydia pneumoniae. J Clin Microbiol 1992; 30:1968-1971.
160. Kuo C-C, Grayston JT. Factors affecting viability and growth in HeLa 229 cells of Chlamydia sp. strain TWAR. J Clin Microbiol 1988; 26:812-815.
161. Kuo C-C. Chlamydia pneumoniae: Culture methods. In: Allegra L, Blasi F, eds. Chlamydia pneumoniae. Milano: Springer, 1999:9-15.
162. Maass M, Dalhof TK. Transport and storage conditions for cultural recovery of Chlamydia pneumoniae. J Clin Microbiol 1995;33:1793-1796.
163. Kuo C-C. Culture and rapid methods in diagnosis of Chlamydia pneumoniae infections. In: Vaheri V, Tilton RC, Balows A, eds. Rapid Methods and Automation in Microbiology and Immunology. Berlin:Springer- Verlag, 1991:299-304.
164. Campbell LA, Melgosa MP, Hamilton DJ, Kuo C-C, Grayston JT. Detection of Chlamydia pneumoniae by polymerase chain reaction. J Clin Microbiol 1992; 30:434-439.
165. Gaydos CA, Quinn TC, Eiden JJ. Identification of the I6S rRNA gene. J Clin Microbiol 1992; 30:796-800.
166. Holland SM, Gaydos CA, Quinn TC. Detection and differentiation of Chlamydia trachomatis, Chlamydia psittaci and Chlamydia pneumoniae by DNA amplification. J Infect Dis 1990; 162:984-987.
167. Grayston JT, Aldous MB, Easton A, Wang S-P, Kuo C-C, Campbell LA, Altman J. Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis. J Infect Dis 1993; 168:1231-1235.
168. Ekman MR, Grayston JT, Visakorpi R, Kleemola M, Kuo C-C, Saikku P. An epidemic of infections due to Chlamydia pneumoniae in military conscripts. Clin Infect Dis 1993; 17:420-425.
169. Wang S-P, Grayston JT. Immunologic relationship between genital TRIC lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test. Am J Ophthalmol 1970; 70:367-334.
170. Hukki-Immonen O, Leinonen M, Saikku P. Diagnosis of Chlamydia pneumoniae by microimmunofluorescence using Kajaani-6 (local epidemic) and TW-183 strains as antigens. In: Mard PA, La Placa M, Ward M, eds. Proceedings of the European Society for Chlamydia Research. The University of Uppsala, Uppsala, Sweden, 1992:183.
171. Black CM, Johnson JE, Farsh CE, Brown TM, Berdal BP. Antigen variation among strains of Chlamydia pneumoniae. J Clin Microbiol 1991; 25:1312-1316.
172. Wang S-P, Grayston JT. The similarity of Chlamydia pneumoniae (TWAR) isolates as antigen in the micro- lmmunofluroescence (MIF) test. In: Orfila J, Byme GL, Chemesky MA, Grayston JT, Jones RP, Ridgeway GL, Saikku P, Schachter J, Stamm WE, Stephens RE, eds. Chlamydial Infections. Bologna, Italy:Societa Edi- trice Esculapio, 1994:549-552.
173. Verkooyen RP, Hazenberg MA, van Haasen GH, van den Bosch JM, Snijder RJ, van Helden HP, Verbrugh HA. Age-related interference with Chlamydia pneumoniae microimmunofluroescence serology due to circulating rheumatoid factor. J Clin Microbiol 1992; 30:1289-1290.
174. Wang SP. Serology for Chlamydia pneumoniae. In: Allegra L, Blasi F, eds. Chlamydia pneumoniae. Milan: Springer-Verlag, 1999:16-23.
175. Jones RB, Van der Pol B, Martin DH, Shepard MK. Partial characterization of Chlamydia trachomatis isolates resistant to multiple antibiotics. J Infect Dis 1990; 162:1309-1315.
176. Black CM, Somani J, Bhullar V, Farshy C, Workowski K. Multiple drug resistant Chlamydia trachomatis associated with clinical treatment failure. Thirteenth Meeting of the Inti Soc for STD Research, July 1999, Denver CO; p 56, abstract #065.
177. Kuo C-C, Wang S-P, Grayston JT. Antimicrobial activity of several antibiotics and a sulfonamide against Chlamydia trachomatis organisms in cell culture. Antimicrob Agents Chemother 1977; 12:80-83.
178. Yang ZP, Kuo C-C, Grayston JT. A mouse model of Chlamydia pneumoniae, strain TWAR pneumonitis. Infect Immun 1993;61:2037-2040.
179. Malinvemi R, Kuo C-C, Campbell LA, Lee A, Grayston JT. Experimental Chlamydia pneumoniae (TWAR) pneumonitis: effect of two antibiotic regimens on the cause and persistence of infection. Antimicrob Agents Chemother 1995; 39:45-49.
180. Addiss DG, Vaughn ML, Ludka D, Pfister J, Davis JP. Decreased prevalence of Chlamydia trachomatis infection associated with a selective screening program in family planning clinics in Wisconsin. Sex Transm Dis 1993;20:28-35.
181. Katz BP, Blythe MJ, Van der Pol B, Jones RB. Declining prevalence of chlamydial infection among inflammatory disease by screening for cervical chlamydia infection. N Engl J Med 1996; 334:1362-1366.
182. Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydia infection. N Engl J Med 1996; 334:1362-1366.
183. Egger M, Low N, Smith GD, Lindblom B, Herrmann B. Screening for chlamydial infections and the risk of ectopic pregnancy in a county in Sweden: ecological analysis. BMJ 1998; 316:1776-1780.